See more : Perception Capital Corp. II (PCCT) Income Statement Analysis – Financial Results
Complete financial analysis of Stem Holdings, Inc. (STMH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Stem Holdings, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- SAR Auto Products Limited (SAPL.BO) Income Statement Analysis – Financial Results
- Neturen Co., Ltd. (5976.T) Income Statement Analysis – Financial Results
- Broncus Holding Corporation (BRNHF) Income Statement Analysis – Financial Results
- Ramsay Health Care Limited (RMSYF) Income Statement Analysis – Financial Results
- Clearside Biomedical, Inc. (CLSD) Income Statement Analysis – Financial Results
Stem Holdings, Inc. (STMH)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://stemholdings.com
About Stem Holdings, Inc.
Stem Holdings, Inc. operates as a vertically-integrated cannabis products and technology company. It engages in the production, distribution, and sale of cannabis and cannabis-infused products. The company's brands include TJ's Gardens, TravisxJames, and Yerba Buena flower and extracts; Cannavore edible confections; Doseology, a CBD mass-market brand; and delivery-as-a-service brands of Budee and Ganjarunner e-commerce platforms. As of September 30, 2021, it had ownership interests in 29 state issued cannabis licenses, including 9 licenses for cannabis cultivation; 3 licenses for cannabis processing; 2 licenses for cannabis wholesale distribution; 3 licenses for hemp production; 7 cannabis dispensary licenses; and 5 licenses for adult-use medical retailers. The company was incorporated in 2016 and is headquartered in Boca Raton, Florida.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 16.56M | 35.77M | 13.97M | 2.45M | 1.30M | 326.04K | 0.00 |
Cost of Revenue | 0.00 | 14.44M | 28.18M | 10.31M | 1.94M | 7.56M | 0.00 | 0.00 |
Gross Profit | 0.00 | 2.12M | 7.59M | 3.67M | 516.00K | -6.26M | 326.04K | 0.00 |
Gross Profit Ratio | 0.00% | 12.82% | 21.21% | 26.25% | 21.05% | -483.44% | 100.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 3.64M | 14.48M | 22.96M | 13.33M | 19.29M | 8.86M | 2.78M | 87.70K |
Selling & Marketing | 103.00K | 266.00K | 368.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 3.75M | 14.48M | 22.96M | 13.33M | 19.29M | 8.86M | 2.78M | 87.70K |
Other Expenses | 0.00 | 1.97M | 2.30M | 0.00 | -40.00K | 44.39K | 0.00 | 0.00 |
Operating Expenses | 3.75M | 14.48M | 22.96M | 13.33M | 19.29M | 8.86M | 2.78M | 87.70K |
Cost & Expenses | 3.75M | 28.92M | 51.14M | 23.64M | 21.22M | 8.86M | 2.78M | 87.70K |
Interest Income | 0.00 | 650.00K | 1.95M | 2.43M | 2.59M | 440.00 | 5.22K | 0.00 |
Interest Expense | 1.24M | 650.00K | 1.88M | 2.43M | 2.59M | 345.66K | 975.00 | 0.00 |
Depreciation & Amortization | -156.29K | 2.49M | 2.24M | 2.37M | 1.23M | 1.36M | 129.22K | 263.10K |
EBITDA | -3.90M | -7.90M | -2.92M | -6.74M | -25.22M | -7.04M | -2.75M | -87.70K |
EBITDA Ratio | 0.00% | -47.68% | -22.13% | -54.05% | -984.54% | -474.75% | -711.38% | 0.00% |
Operating Income | -3.75M | -12.36M | -15.37M | -9.67M | -18.77M | -7.56M | -2.75M | -87.70K |
Operating Income Ratio | 0.00% | -74.61% | -42.98% | -69.17% | -765.89% | -583.44% | -843.73% | 0.00% |
Total Other Income/Expenses | -1.39M | -10.14M | 3.37M | -1.83M | -6.92M | -301.00K | 4.24K | -175.40K |
Income Before Tax | -5.13M | -16.62M | -64.61M | -11.49M | -28.99M | -7.86M | -2.75M | -87.70K |
Income Before Tax Ratio | 0.00% | -100.32% | -180.62% | -82.25% | -1,182.58% | -606.66% | -842.43% | 0.00% |
Income Tax Expense | 0.00 | 10.78M | 3.71M | 1.69M | -7.69M | 44.83K | 975.00 | -263.10K |
Net Income | -19.02M | -27.40M | -68.32M | -13.18M | -21.30M | -7.86M | -2.75M | -87.70K |
Net Income Ratio | 0.00% | -165.40% | -190.99% | -94.34% | -868.87% | -606.66% | -842.43% | 0.00% |
EPS | -5.92 | -12.11 | -42.88 | -21.92 | -75.40 | -94.64 | -49.07 | -3.27 |
EPS Diluted | -5.92 | -12.11 | -42.88 | -21.92 | -75.40 | -94.64 | -49.07 | -3.27 |
Weighted Avg Shares Out | 2.53M | 2.26M | 1.59M | 601.43K | 282.45K | 83.05K | 55.97K | 26.85K |
Weighted Avg Shares Out (Dil) | 2.53M | 2.26M | 1.59M | 601.43K | 282.45K | 83.05K | 55.97K | 26.85K |
Stem Holdings, Inc. d/b/a Driven By Stem Announces Record Sales and Gross Margin for the Third Quarter
Stem Holdings d/b/a Driven By Stem Announces Date of Fiscal 2021 Third Quarter Financial Results Conference Call
The Cheapest And Most Expensive Cannabis Stocks
From GrubHub To Cannabis: An Entrepreneur's Life-Long Bet On Home Deliveries
Driven By Stem CEO, Adam Berk, Provides Shareholder Update During Virtual Road Show on ChannelChek
STEM Holdings, Inc. Discusses The Future of Cannabis eCommerce and Delivery with The Stock Day Podcast
Stem Holdings to Present at Canaccord Genuity's Annual Global Cannabis Virtual Conference on May 11th
Driven By Stem is Expanding into Michigan, the Fourth-Largest U.S. Cannabis Market - Teaming Up with Organic Guyz
Stem Holdings Announces Filing of Final Prospectus
Stem Holdings Announces Participation at Investor Conferences on 4/20
Source: https://incomestatements.info
Category: Stock Reports